vs
CANTALOUPE, INC.（CTLP）与Oncology Institute, Inc.（TOI）财务数据对比。点击上方公司名可切换其他公司
Oncology Institute, Inc.的季度营收约是CANTALOUPE, INC.的1.8倍（$142.0M vs $78.7M），CANTALOUPE, INC.净利率更高（-0.1% vs -5.3%，领先5.2%），Oncology Institute, Inc.同比增速更快（41.6% vs 6.8%），Oncology Institute, Inc.自由现金流更多（$2.2M vs $-614.0K），过去两年Oncology Institute, Inc.的营收复合增速更高（22.5% vs 7.7%）
坎塔卢波（原美国技术公司）是一家美国科技企业，核心业务为ePort无现金支付受理技术，依托持专利的PCI合规ePort Connect服务开展运营。该服务可通过无线方式为消费者提供信用卡、借记卡以及Apple Pay、Google Pay等NFC钱包支付选项，同时为运营商提供遥测与机器间通信服务，ePort技术主要应用于...
肿瘤研究所股份有限公司是一家专注于肿瘤诊疗领域的专业医疗企业，提供循证抗癌治疗方案、临床试验参与通道及配套支持护理服务，主要面向美国境内各类癌症患者，协同医疗从业者优化诊疗效果。
CTLP vs TOI — 直观对比
营收规模更大
TOI
是对方的1.8倍
$78.7M
营收增速更快
TOI
高出34.8%
6.8%
净利率更高
CTLP
高出5.2%
-5.3%
自由现金流更多
TOI
多$2.8M
$-614.0K
两年增速更快
TOI
近两年复合增速
7.7%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $78.7M | $142.0M |
| 净利润 | $-70.0K | $-7.5M |
| 毛利率 | — | — |
| 营业利润率 | 2.0% | -4.9% |
| 净利率 | -0.1% | -5.3% |
| 营收同比 | 6.8% | 41.6% |
| 净利润同比 | -101.4% | 43.0% |
| 每股收益（稀释后） | $0.00 | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTLPTOI
| Q4 25 | $78.7M | $142.0M | ||
| Q3 25 | $80.9M | $136.6M | ||
| Q2 25 | $82.6M | $119.8M | ||
| Q1 25 | $75.4M | $104.4M | ||
| Q4 24 | $73.7M | $100.3M | ||
| Q3 24 | $70.8M | $99.9M | ||
| Q2 24 | $72.7M | $98.6M | ||
| Q1 24 | $67.9M | $94.7M |
净利润CTLPTOI
| Q4 25 | $-70.0K | $-7.5M | ||
| Q3 25 | $-919.0K | $-16.5M | ||
| Q2 25 | $6.8M | $-17.0M | ||
| Q1 25 | $49.2M | $-19.6M | ||
| Q4 24 | $5.0M | $-13.2M | ||
| Q3 24 | $3.6M | $-16.1M | ||
| Q2 24 | $2.2M | $-15.5M | ||
| Q1 24 | $4.7M | $-19.9M |
毛利率CTLPTOI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 39.6% | — |
营业利润率CTLPTOI
| Q4 25 | 2.0% | -4.9% | ||
| Q3 25 | 2.0% | -5.9% | ||
| Q2 25 | 6.3% | -9.4% | ||
| Q1 25 | 9.1% | -9.5% | ||
| Q4 24 | 8.4% | -11.9% | ||
| Q3 24 | 5.8% | -13.9% | ||
| Q2 24 | 4.9% | -16.6% | ||
| Q1 24 | 6.3% | -19.0% |
净利率CTLPTOI
| Q4 25 | -0.1% | -5.3% | ||
| Q3 25 | -1.1% | -12.1% | ||
| Q2 25 | 8.3% | -14.2% | ||
| Q1 25 | 65.2% | -18.8% | ||
| Q4 24 | 6.7% | -13.1% | ||
| Q3 24 | 5.0% | -16.1% | ||
| Q2 24 | 3.0% | -15.7% | ||
| Q1 24 | 6.9% | -21.0% |
每股收益（稀释后）CTLPTOI
| Q4 25 | $0.00 | $-0.04 | ||
| Q3 25 | $-0.02 | $-0.14 | ||
| Q2 25 | $0.10 | $-0.15 | ||
| Q1 25 | $0.65 | $-0.21 | ||
| Q4 24 | $0.07 | $-0.14 | ||
| Q3 24 | $0.04 | $-0.18 | ||
| Q2 24 | $0.03 | $-0.17 | ||
| Q1 24 | $0.06 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $53.0M | — |
| 总债务越低越好 | $37.7M | — |
| 股东权益账面价值 | $252.5M | $-15.7M |
| 总资产 | $381.9M | $164.7M |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资CTLPTOI
| Q4 25 | $53.0M | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | $51.1M | — | ||
| Q1 25 | $46.3M | — | ||
| Q4 24 | $27.7M | — | ||
| Q3 24 | $33.1M | — | ||
| Q2 24 | $58.9M | $9.9M | ||
| Q1 24 | $50.2M | $29.8M |
总债务CTLPTOI
| Q4 25 | $37.7M | — | ||
| Q3 25 | $38.3M | — | ||
| Q2 25 | $38.7M | — | ||
| Q1 25 | $39.2M | — | ||
| Q4 24 | $37.0M | — | ||
| Q3 24 | $37.3M | — | ||
| Q2 24 | $37.5M | — | ||
| Q1 24 | $38.1M | — |
股东权益CTLPTOI
| Q4 25 | $252.5M | $-15.7M | ||
| Q3 25 | $251.8M | $-12.3M | ||
| Q2 25 | $251.0M | $-9.0M | ||
| Q1 25 | $240.7M | $5.1M | ||
| Q4 24 | $190.1M | $3.6M | ||
| Q3 24 | $186.2M | $15.5M | ||
| Q2 24 | $181.7M | $29.2M | ||
| Q1 24 | $178.8M | $41.3M |
总资产CTLPTOI
| Q4 25 | $381.9M | $164.7M | ||
| Q3 25 | $389.5M | $163.6M | ||
| Q2 25 | $381.9M | $159.8M | ||
| Q1 25 | $370.5M | $164.0M | ||
| Q4 24 | $303.0M | $172.7M | ||
| Q3 24 | $312.1M | $179.2M | ||
| Q2 24 | $335.6M | $179.6M | ||
| Q1 24 | $319.9M | $204.5M |
负债/权益比CTLPTOI
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.21× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.1M | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $-614.0K | $2.2M |
| 自由现金流率自由现金流/营收 | -0.8% | 1.5% |
| 资本支出强度资本支出/营收 | 4.8% | 0.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $25.8M | $-27.8M |
8季度趋势，按日历期对齐
经营现金流CTLPTOI
| Q4 25 | $3.1M | $3.2M | ||
| Q3 25 | $7.0M | $-12.6M | ||
| Q2 25 | $9.4M | $-10.2M | ||
| Q1 25 | $22.4M | $-5.0M | ||
| Q4 24 | $522.0K | $4.2M | ||
| Q3 24 | $-12.0M | $819.0K | ||
| Q2 24 | $14.3M | $-15.7M | ||
| Q1 24 | $14.7M | $-15.9M |
自由现金流CTLPTOI
| Q4 25 | $-614.0K | $2.2M | ||
| Q3 25 | $3.5M | $-13.2M | ||
| Q2 25 | $4.3M | $-11.4M | ||
| Q1 25 | $18.6M | $-5.3M | ||
| Q4 24 | $-3.8M | $2.4M | ||
| Q3 24 | $-15.8M | $417.0K | ||
| Q2 24 | $8.5M | $-17.5M | ||
| Q1 24 | $11.4M | $-16.5M |
自由现金流率CTLPTOI
| Q4 25 | -0.8% | 1.5% | ||
| Q3 25 | 4.4% | -9.7% | ||
| Q2 25 | 5.3% | -9.5% | ||
| Q1 25 | 24.6% | -5.1% | ||
| Q4 24 | -5.1% | 2.4% | ||
| Q3 24 | -22.3% | 0.4% | ||
| Q2 24 | 11.7% | -17.7% | ||
| Q1 24 | 16.9% | -17.4% |
资本支出强度CTLPTOI
| Q4 25 | 4.8% | 0.7% | ||
| Q3 25 | 4.2% | 0.4% | ||
| Q2 25 | 6.2% | 1.0% | ||
| Q1 25 | 5.1% | 0.3% | ||
| Q4 24 | 5.8% | 1.8% | ||
| Q3 24 | 5.4% | 0.4% | ||
| Q2 24 | 7.9% | 1.9% | ||
| Q1 24 | 4.8% | 0.6% |
现金转化率CTLPTOI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.38× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | -3.36× | — | ||
| Q2 24 | 6.47× | — | ||
| Q1 24 | 3.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTLP
| Transaction Processing | $47.9M | 61% |
| Subscription Revenue | $21.8M | 28% |
| Products | $9.0M | 11% |
TOI
| Other | $82.1M | 58% |
| Fee For Service | $36.3M | 26% |
| Capitated Revenue | $23.6M | 17% |
